© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Cidofovir Dihydrate sits among the notable antivirals in medicine, strictly a synthetic nucleoside phosphonate analog. Researchers look to this compound for treatment of viral infections, especially when other agents fall short. Molecular formula is C8H14N3O6P·2H2O, making it a deliberate choice in laboratories intent on curbing select DNA viruses, such as cytomegalovirus. Cidofovir Dihydrate enters therapeutic protocols after chemists produce it under controlled conditions, yielding a stable, workable form that meets rigorous pharmaceutical standards. This compound’s presence often reflects ongoing work in virology, where its effects and risks both demand attention.
The substance typically appears as a white to off-white powder or crystalline solid, dense and persistent in form. Packing density falls near 1.63 g/cm³, a number derived from established measurement techniques in analytical chemistry. Each batch displays fine flakes, granular powder, or crystalline pearls, reflecting differences in crystallization or milling methods. The robust crystalline structure ensures stability even when atmospheric conditions shift, holding up under storage at room temperature, away from prolonged light or humidity. Dissolution in water or buffer solutions proves straightforward, allowing for accurate preparation of suspensions or infusion-grade liquids. Molecular structure features a five-membered ring attached to a cytosine moiety and a phosphorus oxyanion, two water molecules further stabilizing the solid through hydrogen bonds. Such pairing confers solubility and chemical reactivity. Under polarized light, the crystals maintain purity, as measured by standard tests.
Cidofovir Dihydrate enters commerce under tight regulation, with each shipment assigned precise quality metrics. Purity often exceeds 98% based on HPLC, ensuring minimal contamination or by-product. Moisture content, pH values, and melting range round out the main metrics reported to buyers and inspectors. Manufacturers label the raw material under the Harmonized System (HS) Code 2934999099, which classifies these unique chemical entities among pharmaceuticals not elsewhere specified. This code assists governments in tracking cross-border shipments, ensuring compliance with safety standards.
Cidofovir Dihydrate usually arrives as a finely milled powder, although some lots emerge as small crystals or compressed flakes. Laboratory use sees the solid dissolved easily in water to yield a clear, colorless solution. Liquid preparations, once mixed, demand cold storage or refrigerated transport to maintain stability, while dry powder travels less risk of degradation.
On a molecular scale, this antiviral boasts a formula weight of about 315.2 g/mol (anhydrous base); dihydrate form measures higher due to the bound water. Each molecule brings together phosphorus, carbon, hydrogen, nitrogen, and oxygen, arranged to mimic natural nucleotides. The phosphate group acts a key player, attracting water molecules and establishing hydrogen-bonded layers in the solid. Chemists and biologists both weigh the charge, polarity, and solubility profile since these properties drive both laboratory handling and biological activity. The acidic side renders the powder somewhat hygroscopic, and the compound quickly dissolves in water, forming a mildly acidic solution.
No chemical of this type enters a laboratory without proper hazard and safety documentation. Although Cidofovir Dihydrate provides clinical benefit, the raw material can harm unprotected skin, and accidental inhalation or ingestion can trigger toxicity or allergic reactions. Laboratory teams equip themselves with gloves, goggles, and masks, using fume hoods for weighing and dissolving the powder. Safety data sheets list potential health hazards, from mild eye or skin irritation to more severe risks if significant exposure occurs, particularly via injection or broken skin. In medical settings, risk of nephrotoxicity stands out, prompting stringent patient monitoring with any clinical use. Spill management procedures cover accidental releases, calling for prompt cleanup with damp cloths and secure container disposal.
Raw Cidofovir Dihydrate flows from chemical plants to pharmaceutical firms and research labs, serving as a critical starting point for formulating antiviral injections. Only rigorously controlled facilities handle its production due to the need for ultrapure, accurately characterized lot numbers. Chemists rely on traceability from supplier through to patient dose, ensuring each gram meets regulatory scrutiny. Approval for shipment follows months of documentation, inspection, and site audits.
Experience in pharmaceutical manufacturing underscores the need for thorough knowledge of every compound handled, especially one like Cidofovir Dihydrate. Quality-controlled production safeguards both user and patient, and guardrails on handling build confidence in results. Regulatory coding and scientific reporting ease movement across borders, so long as every party respects safety data and best practice. Whether weighed as flakes, measured out as powder, or dissolved to make solution, the material deserves careful respect. Healthcare improves only if each set of hands along the way understands what limits and potentials accompany every vial, every package, every dose.
